Quality Chemical Industries Past Earnings Performance
Past criteria checks 5/6
Quality Chemical Industries has been growing earnings at an average annual rate of 51.2%, while the Pharmaceuticals industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 7% per year. Quality Chemical Industries's return on equity is 25.7%, and it has net margins of 17%.
Key information
51.2%
Earnings growth rate
51.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 7.0% |
| Return on equity | 25.7% |
| Net Margin | 17.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Quality Chemical Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 296,387 | 50,254 | 64,048 | 0 |
| 30 Jun 24 | 280,864 | 41,007 | 60,654 | 0 |
| 31 Mar 24 | 265,340 | 31,760 | 57,261 | 0 |
| 31 Mar 23 | 221,466 | 18,987 | 36,350 | 0 |
| 31 Mar 22 | 267,432 | 24,051 | 29,562 | 0 |
| 31 Mar 21 | 284,540 | -10,538 | 58,962 | 0 |
| 31 Mar 20 | 192,682 | -23,073 | 34,778 | 0 |
| 31 Dec 19 | 190,141 | -17,047 | 35,153 | 0 |
| 30 Sep 19 | 187,599 | -11,020 | 44,684 | 0 |
| 30 Jun 19 | 191,368 | -2,117 | 46,773 | 0 |
| 31 Mar 19 | 195,136 | 6,786 | 36,527 | 0 |
| 31 Dec 18 | 217,679 | 26,430 | 41,009 | 0 |
| 30 Sep 18 | 240,222 | 46,075 | 50,245 | 0 |
| 30 Jun 18 | 233,769 | 45,351 | 48,363 | 0 |
| 31 Mar 18 | 227,315 | 44,627 | 43,590 | 0 |
| 31 Mar 17 | 211,733 | 42,174 | 47,095 | 0 |
| 31 Mar 16 | 164,050 | 42,843 | 30,330 | 0 |
| 31 Mar 15 | 120,193 | 32,447 | 22,711 | 0 |
| 31 Dec 13 | 89,788 | 8,280 | 20,543 | 0 |
Quality Earnings: QCIL has a high level of non-cash earnings.
Growing Profit Margin: QCIL's current net profit margins (17%) are higher than last year (10.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: QCIL has become profitable over the past 5 years, growing earnings by 51.2% per year.
Accelerating Growth: QCIL's earnings growth over the past year (98.1%) exceeds its 5-year average (51.2% per year).
Earnings vs Industry: QCIL earnings growth over the past year (98.1%) exceeded the Pharmaceuticals industry 20.8%.
Return on Equity
High ROE: QCIL's Return on Equity (25.7%) is considered high.